In a large, gender comparison study, researchers found that women with Hepatitis C are more likely than men to have several disadvantages after undergoing a liver transplant.

Recent data from a Phase II trial claims that twice daily dosing of telaprevir cured Hepatitis C in over 80 participants.

Learn about the legitimate reasons to believe Hepatitis C is curable - and reasons to believe otherwise.

If choosing a doctor to help you fight the Hepatitis C virus feels overwhelming, you are not alone. To identify which physician fits your needs best, the nation's largest health insurer has developed a rating system for patients to evaluate

By expanding the applicability of cellular array technology, learn how San Diego researchers may have found a direction for the therapeutic intervention of liver fibrosis.